Skip to content
Partnerships
News
Contact
Fore Biotherapeutics
Pipeline
Science
Plixorafenib Program
Publications
Patients
Our Science Explained
Clinical Trials
Forte Trial
Expanded Access
Company
About Us
People
Leadership
Investors
Careers
Governance
Search
Pipeline
Science
Plixorafenib Program
Publications
Patients
Our Science Explained
Clinical Trials
Forte Trial
Expanded Access
Company
About Us
People
Leadership
Investors
Careers
Governance
Partnerships
News
Contact
Science
Publications
Read more
Plixorafenib Program
Plixorafenib is an investigational drug identified by our Foresight platform for its ability to inhibit a wide range of untreated mutations in cancer...
Read more